Market Place
Sourcing Support
Corbus Pharma Joins BMO 2026 Metabolic Health Summit
18 Mar 2026 //
GLOBENEWSWIRE
Corbus Pharma Reveals Q4 2025 Financials And Corporate Update
09 Mar 2026 //
GLOBENEWSWIRE
Corbus Pharma To Present At 36th Oppenheimer Healthcare Conf
12 Feb 2026 //
GLOBENEWSWIRE
Corbus Pharma Presents at 44th J.P. Morgan Healthcare Conference
05 Jan 2026 //
GLOBENEWSWIRE
Corbus Pharma Reports Results from Phase 1a Study of CRB-913
11 Dec 2025 //
GLOBENEWSWIRE
Corbus Pharma To Join Investor Conferences
06 Nov 2025 //
GLOBENEWSWIRE
Corbus Pharmaceuticals Announces Pricing of Public Offering
31 Oct 2025 //
GLOBENEWSWIRE
Corbus Pharmaceuticals Announces Proposed Public Offering
30 Oct 2025 //
GLOBENEWSWIRE
Corbus Pharma Joins Piper Sandler Oncology Symposium
07 Oct 2025 //
GLOBENEWSWIRE
Corbus Pharma Hosts In-Person & Virtual Kol Event At Esmo 2025
22 Sep 2025 //
GLOBENEWSWIRE
Corbus Pharmaceuticals Reports Q2 2025 Financials Result, Updates
05 Aug 2025 //
GLOBENEWSWIRE
Corbus Starts Dose-Escalation for Obesity Drug CRB-913
30 Jun 2025 //
GLOBENEWSWIRE
Corbus Pharmaceuticals at 3rd Annual Piper Obesity Symposium
24 Jun 2025 //
GLOBENEWSWIRE
Corbus Pharmaceuticals at Jefferies Global Healthcare Conference
22 May 2025 //
GLOBENEWSWIRE
Corbus Pharmaceuticals Names Rachelle Jacques as Board Chair
19 May 2025 //
GLOBENEWSWIRE
Corbus Pharmaceuticals to Present at 2025 RBC Conference
08 May 2025 //
GLOBENEWSWIRE
Corbus Pharmaceuticals Reports Q1 2025 Results and Update
06 May 2025 //
GLOBENEWSWIRE
Corbus Pharmaceuticals Starts Phase 1 Study of CRB-913 for Obesity
28 Mar 2025 //
GLOBENEWSWIRE
Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results
11 Mar 2025 //
GLOBENEWSWIRE
Corbus Pharma to Present at the 43rd Annual J.P. Morgan Conference
06 Jan 2025 //
GLOBENEWSWIRE
Corbus Pharma to Present at Evercore HealthCONx Conference
21 Nov 2024 //
GLOBENEWSWIRE
Corbus Pharma to Present at Jefferies London Health Conference
12 Nov 2024 //
GLOBENEWSWIRE
Corbus Pharma Q3 2024 Results & Corporate Update
07 Nov 2024 //
GLOBENEWSWIRE
Corbus Pharma Presents CRB-913 Data at ObesityWeek® 2024
04 Nov 2024 //
GLOBENEWSWIRE
Corbus Pharma to Present at Healthcare Innovation Conference
29 Oct 2024 //
GLOBENEWSWIRE
Corbus Pharmaceuticals To Participate In BMO Oncology Summit
26 Sep 2024 //
GLOBENEWSWIRE
Corbus Pharmaceuticals Appoints Winston Kung To Board Of Directors
20 Aug 2024 //
GLOBENEWSWIRE
Corbus Pharmaceuticals Reports Q2 2024 Results And Corporate Update
06 Aug 2024 //
GLOBENEWSWIRE
Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in August
30 Jul 2024 //
GLOBENEWSWIRE
Corbus At Goldman Sachs Global Healthcare Conference
30 May 2024 //
GLOBENEWSWIRE
Corbus Pharma At RBC Healthcare Conference 2024
09 May 2024 //
GLOBENEWSWIRE
Corbus Reports Q1 2024 Financials And Corporate Update
07 May 2024 //
GLOBENEWSWIRE
Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum
01 May 2024 //
GLOBENEWSWIRE
Corbus Abstract Accepted for ASCO 2024 Presentation
24 Apr 2024 //
GLOBENEWSWIRE
Corbus Reports Fourth Quarter and Year-End 2023 Financial Results
12 Mar 2024 //
GLOBENEWSWIRE
Corbus to Participate in the BMO Capital Markets Inaugural Obesity Summit
06 Mar 2024 //
GLOBENEWSWIRE
Corbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer
28 Feb 2024 //
GLOBENEWSWIRE
Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Conference
06 Feb 2024 //
GLOBENEWSWIRE
Corbus Pharmaceuticals Announces Pricing of Public Offering
31 Jan 2024 //
GLOBENEWSWIRE
Corbus Pharmaceuticals Announces Proposed Public Offering
30 Jan 2024 //
GLOBENEWSWIRE
Corbus Pharma Announces Abstract Accepted for Presentation at 2024 ASCO GU
18 Dec 2023 //
GLOBENEWSWIRE
Corbus Announces Publication of Data for its Novel Cannabinoid Type-1 Receptor
17 Oct 2023 //
GLOBENEWSWIRE
Corbus Reports Second Quarter 2023 Financial Results
08 Aug 2023 //
PR NEWSWIRE
Corbus Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference
31 Jul 2023 //
PR NEWSWIRE
Corbus Pharmaceuticals Set to Join Russell Microcap® Index
26 Jun 2023 //
PR NEWSWIRE
Corbus Pharmaceuticals to Participate in 2023 Jefferies Healthcare Conference
31 May 2023 //
PR NEWSWIRE
Corbus Pharmaceuticals Reports1Q 2023 FYR and Provides Corporate Update
09 May 2023 //
PR NEWSWIRE
Corbus Pharma Reports Fourth Quarter 2022 and Year-End Financial Results
07 Mar 2023 //
PR NEWSWIRE
Corbus Pharmaceuticals Expands Board of Directors with Appointment of Yong Ben
06 Mar 2023 //
PR NEWSWIRE
Corbus to Present at the Oppenheimer 33rd Annual Healthcare Conference
02 Mar 2023 //
PR NEWSWIRE
Corbus Presents Latest Preclinical Data for CRB-601 at the Society for (SITC)
10 Nov 2022 //
PRNEWSWIRE
Corbus Reports3Q 2022 Financial Results and Provides Corporate Update
08 Nov 2022 //
PRNEWSWIRE
Corbus to Present Pre-Clinical Data for CRB-601 at the SITC 37th Annual Meeting
14 Oct 2022 //
PRNEWSWIRE
Corbus Pharma Reports Second Quarter 2022 Financial Results
09 Aug 2022 //
PRNEWSWIRE
Corbus Presents Latest Preclinical Data for CRB-601
11 May 2022 //
PRNEWSWIRE
Corbus Presents First Preclinical Data for CRB-601 at the AACR
08 Apr 2022 //
PRNEWSWIRE
Corbus Pharma Reports Q4 and Year-End 2021 Financial Results
08 Mar 2022 //
PRNEWSWIRE
Corbus snags Takeda`s cancer leader to boost early-stage assets
08 Dec 2021 //
FIERCEBIOTECH
Corbus notches another trial setback in a long line of failures
25 Jun 2021 //
FIERCEBIOTECH
Corbus Announces Completion of Enrollment in NIH-Sponsored Phase 2 Study
20 Apr 2021 //
GLOBENEWSWIRE
